Source: BioPortfolio

ASCEND Therapeutics: Ascend Therapeutics US LLC Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12042018 Prices from USD $250

SummaryAscend Therapeutics US LLC Ascend Therapeutics a subsidiary of Besins Healthcare SA is a healthcare products provider that discovers develops and markets transdermal drug delivery products. The company's product comprises estrogel. Its estrogel is a...

Read full article »
ASCEND Therapeutics's Competitors | ASCEND Therapeutics's News | ASCEND Therapeutics's Financials
Stay up-to-date with the latest news on ASCEND Therapeutics
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Nicholas Hart's photo - President & CEO of ASCEND Therapeutics

President & CEO

Nicholas Hart

CEO Approval Rating

81/100

Read more
Stay up-to-date with the latest news on ASCEND Therapeutics